Login to Your Account

CERN Spinout AAA Picking Up Speed in Lutathera Trial

By Nuala Moran
Staff Writer

Wednesday, September 26, 2012
LONDON – Advanced Accelerator Applications SA has set itself the challenge of servicing 42 centers across the U.S. and Europe, in a 200-patient Phase III trial of Lutathera, a radiolabeled peptide that has a shelf life of only 72 hours.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription